Clinical Trial Update: Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab [Phase 1, Phase 2]

View source ↗

Summary

Strand Therapeutics is conducting a Phase 1/2 trial of intratumoral STX-001 in advanced solid tumors, as monotherapy or in combination with pembrolizumab, and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• STX-001

Snippet

Sponsor: Strand Therapeutics Inc. | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING